Additionally, it was shown that the expression of several miRNAs—including miR-29a and miR-29b-1—which control the production of APP and the beta-site APP-cleaving enzyme 1 (BACE1), was downregulated in AD brains. This evidence concerns the gene BACE1 and Alzheimer disease.